Viewing Study NCT02376751


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2026-03-01 @ 1:45 PM
Study NCT ID: NCT02376751
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2016-06-08
First Post: 2015-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2015-02-25
First Submit QC Date: None
Study First Post Date: 2015-03-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-06-06
Last Update Post Date: 2016-06-08
Last Update Post Date Type: ESTIMATED